Dysport 500 Units

Description

Dysport 500 Units (abobotulinumtoxinA) is a purified botulinum toxin type A complex manufactured by Ipsen (distributed by Galderma in many markets). Each vial contains 500 units of lyophilized neurotoxin powder, reconstituted with preservative-free 0.9% sodium chloride solution before injection. Dysport works by inhibiting acetylcholine release at the neuromuscular junction, producing precise, temporary muscle paralysis or reduced glandular activity—making it a trusted choice for both cosmetic wrinkle reduction and medical neuromuscular conditions.

Aesthetic Uses

Dysport 500 Units is FDA-approved and globally used for the temporary improvement of moderate to severe glabellar frown lines (the “11s” between the eyebrows). The 500-unit vial is particularly practical for:

• Full-face or multi-area treatments in one session
• High-volume aesthetic clinics treating multiple patients
• Patients requiring higher total doses (stronger facial muscles, men, or combination protocols)
• Off-label aesthetic indications such as forehead lines, crow’s feet, bunny lines, masseter reduction (jaw slimming), platysmal bands, perioral rhytids, gummy smile, or hyperhidrosis

Typical cosmetic doses range from 50–100 units per session (glabellar lines usually 50 units spread over 5 points), with onset visible in 2–5 days (often faster than some other toxins), peak effect at 7–14 days, and duration generally 3–5 months (comparable or slightly shorter than Botox in some studies but with a broader diffusion profile for natural blending).

Therapeutic Uses

Dysport is approved for several medical indications, including:

• Cervical dystonia (abnormal head position and neck pain)
• Upper limb spasticity in adults
• Lower limb spasticity in pediatric patients ≥2 years
• Focal hyperhidrosis (in some regions)

Therapeutic doses vary significantly (e.g., 500–1,000+ units total for dystonia/spasticity), requiring expert anatomical placement and often electromyography guidance.

Administration & Handling

• Reconstitute with 2.5 mL (for 20 U/0.1 mL) or up to 5–10 mL of sterile, preservative-free saline depending on desired concentration and indication
• Use within 24 hours when refrigerated (2–8°C)
• Inject via fine-gauge needles (30–33G) or cannulas in aesthetic applications

Safety & Side Effects

Common side effects are mild and transient: injection-site pain, swelling, bruising, headache, eyelid ptosis, dry eyes, or mild flu-like symptoms. Serious but rare risks include distant spread of toxin effects (dysphagia, respiratory distress), allergic reactions, or antibody-mediated resistance with repeated use. Contraindications include hypersensitivity to botulinum toxin or human albumin, active infection at injection site, and certain neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome, ALS).

As of 2026, Dysport 500 Units is approved in over 70 countries (including the US, Europe, Asia, Latin America, and the Middle East) and is widely used due to its high purity, consistent potency, favorable diffusion characteristics, and competitive pricing. The 500-unit vial provides excellent flexibility and cost-efficiency for clinics and practitioners. Dysport must be administered only by qualified healthcare professionals (dermatologists, plastic surgeons, neurologists, etc.) trained in botulinum toxin injection techniques, with thorough patient assessment, informed consent, and follow-up. Always source genuine Dysport from authorized distributors to ensure authenticity, potency, and safety.